US EditionZimmer Biomet Acquisition of Monogram Technologies to Expand Capacity in Robotics Devices
UNITED STATES, JUL 14 – Zimmer Biomet will pay $177 million upfront with milestone payments through 2030 to enhance its orthopedic robotics and pursue a fully autonomous surgical robot, boosting revenue from 2027, officials said.
- On July 14, 2025, Zimmer Biomet Holdings, Inc. and Monogram Technologies Inc. announced a definitive agreement, detailing a $177 million equity value and $168 million enterprise value.
- Both companies’ boards unanimously approved the deal, as it bolsters Zimmer Biomet’s lead in a fast-growing robotics segment.
- The deal includes non-tradeable contingent value rights, Zimmer Biomet will fund it with cash and debt, backed by ROSA’s global installations.
- Zimmer Biomet expects revenue growth to begin in 2027, via broader robotic knee adoption, and gains a path to full surgical robot autonomy.
- Pending regulatory and shareholder approvals, the merger is expected to close later this year, with ROSA Knee with OptimiZe FDA clearance anticipated in the same period.
Insights by Ground AI
Does this summary seem wrong?
25 Articles
25 Articles
The Globe & Mail+8 Reposted by 8 other sources
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions
Detailed price information for Zimmer Biomet Holdings (ZBH-N) from The Globe and Mail including charting and trades.
·Canada
Read Full ArticleCoverage Details
Total News Sources25
Leaning Left0Leaning Right1Center8Last UpdatedBias Distribution89% Center
Bias Distribution
- 89% of the sources are Center
89% Center
C 89%
11%
Factuality
To view factuality data please Upgrade to Premium
